Immediate Impact
70 standout
Citing Papers
Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial
2022 Standout
Diffuse Large B-Cell Lymphoma
2021 Standout
Works of Bertjan Arends being referenced
The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials
2008
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Bertjan Arends | 205 | 288 | 43 | 72 | 6 | 470 | |
| P. B. Kunkler | 203 | 188 | 48 | 45 | 15 | 531 | |
| Jacqueline Foidart-Willems | 144 | 250 | 30 | 25 | 8 | 452 | |
| Paul Thimister | 241 | 204 | 24 | 92 | 10 | 482 | |
| Eija Sutinen | 230 | 324 | 11 | 30 | 11 | 558 | |
| Lise Bettman | 130 | 289 | 49 | 27 | 12 | 530 | |
| Edmund E. Kim | 153 | 249 | 34 | 20 | 9 | 561 | |
| Rafael Fernandes Nunes | 260 | 233 | 15 | 24 | 14 | 473 | |
| S.L. Bacharach | 218 | 400 | 37 | 41 | 5 | 542 | |
| Nielson Tse | 157 | 340 | 59 | 35 | 10 | 538 | |
| Edward J. Somer | 110 | 248 | 179 | 20 | 11 | 414 |
All Works
Loading papers...